Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Schizophrenia Drug Market


6. Market Share Analysis – Global Schizophrenia Drug Market

6.1 By Treatment
6.2 By Therapeutic Class
6.3 By Distribution Channel
6.4 By Country


7. Treatment – Global Schizophrenia Drug Market

7.1 Oral
7.2 Injectable


8. Therapeutic Class – Global Schizophrenia Drug Market

8.1 Second Generation
8.2 Third Generation
8.3 Others


9. Distribution Channel – Global Schizophrenia Drug Market

9.1 Hospital Pharmacies
9.2 Retail Pharmacies
9.3 Online Pharmacies


10. Region – Global Schizophrenia Drug Market

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 South America

10.2.1 Brazil
10.2.2 Mexico

10.3 Europe

10.3.1 United Kingdom
10.3.2 Germany
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Netherlands

10.4 Asia Pacific

10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Australia

10.5 Middle East & Africa

10.5.1 South Africa
10.5.2 UAE

10.6 Rest of the World


11. Porter Five Forces

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes


12. SWOT Analysis

12.1 Strengths
12.2 Weaknesses
12.3 Opportunities
12.4 Threats


13. Company Analysis

13.1 H. Lundbeck A/S

13.1.1 Overview
13.1.2 Business Strategy
13.1.3 Financial Insight

13.2 Pfizer Inc.

13.2.1 Overview
13.2.2 Business Strategy
13.2.3 Financial Insight

13.3 AbbVie

13.3.1 Overview
13.3.2 Business Strategy
13.3.3 Financial Insight

13.4 AstraZeneca

13.4.1 Overview
13.4.2 Business Strategy
13.4.3 Financial Insight

13.5 Bristol Myers Squibb

13.5.1 Overview
13.5.2 Business Strategy
13.5.3 Financial Insight

13.6 Eli Lilly

13.6.1 Overview
13.6.2 Business Strategy
13.6.3 Financial Insight

13.7 GlaxoSmithKline

13.7.1 Overview
13.7.2 Business Strategy
13.7.3 Financial Insight

13.8 Johnson & Johnson

13.8.1 Overview
13.8.2 Business Strategy
13.8.3 Financial Insight

13.9 Novartis AG

13.9.1 Overview
13.9.2 Business Strategy
13.9.3 Financial Insight

13.10 Takeda Pharmaceuticals

13.10.1 Overview
13.10.2 Business Strategy
13.10.3 Financial Insight



List of Figures

Figure-01: Global – Schizophrenia Drug Market (Billion US$), 2018 – 2023
Figure-02: Global – Forecast for Schizophrenia Drug Market (Billion US$), 2024 – 2030
Figure-03: Treatment – Oral Market (Million US$), 2018 – 2023
Figure-04: Treatment – Forecast for Oral Market (Million US$), 2024 – 2030
Figure-05: Treatment – Injectable Market (Million US$), 2018 – 2023
Figure-06: Treatment – Forecast for Injectable Market (Million US$), 2024 – 2030
Figure-07: Therapeutic Class – Second Generation Market (Million US$), 2018 – 2023
Figure-08: Therapeutic Class – Forecast for Second Generation Market (Million US$), 2024 – 2030
Figure-09: Therapeutic Class – Third Generation Market (Million US$), 2018 – 2023
Figure-10: Therapeutic Class – Forecast for Third Generation Market (Million US$), 2024 – 2030
Figure-11: Therapeutic Class – Others Market (Million US$), 2018 – 2023
Figure-12: Therapeutic Class – Forecast for Others Market (Million US$), 2024 – 2030
Figure-13: Distribution Channel – Hospital Pharmacies Market (Million US$), 2018 – 2023
Figure-14: Distribution Channel – Forecast for Hospital Pharmacies Market (Million US$), 2024 – 2030
Figure-15: Distribution Channel – Retail Pharmacies Market (Million US$), 2018 – 2023
Figure-16: Distribution Channel – Forecast for Retail Pharmacies Market (Million US$), 2024 – 2030
Figure-17: Distribution Channel – Online Pharmacies Market (Million US$), 2018 – 2023
Figure-18: Distribution Channel – Forecast for Online Pharmacies Market (Million US$), 2024 – 2030
Figure-19: United States – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-20: United States – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-21: Canada – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-22: Canada – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-23: Brazil – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-24: Brazil – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-25: Mexico – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-26: Mexico – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-27: United Kingdom – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-28: United Kingdom – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-29: Germany – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-30: Germany – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-31: France – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-32: France – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-33: Italy – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-34: Italy – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-35: Spain – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-36: Spain – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-37: Netherlands – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-38: Netherlands – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-39: China – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-40: China – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-41: Japan – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-42: Japan – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-43: India – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-44: India – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-45: South Korea – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-46: South Korea – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-47: Australia – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-48: Australia – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-49: South Africa – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-50: South Africa – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-51: UAE – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-52: UAE – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-53: Rest of the World – Schizophrenia Drug Market (Million US$), 2018 – 2023
Figure-54: Rest of the World – Forecast for Schizophrenia Drug Market (Million US$), 2024 – 2030
Figure-55: H. Lundbeck A/S – Global Revenue (Million US$), 2018 – 2023
Figure-56: H. Lundbeck A/S – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-57: Pfizer Inc. – Global Revenue (Billion US$), 2018 – 2023
Figure-58: Pfizer Inc. – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-59: AbbVie – Global Revenue (Billion US$), 2018 – 2023
Figure-60: AbbVie – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-61: AstraZeneca – Global Revenue (Billion US$), 2018 – 2023
Figure-62: AstraZeneca – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-63: Bristol Myers Squibb – Global Revenue (Billion US$), 2018 – 2023
Figure-64: Bristol Myers Squibb – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-65: Eli Lilly – Global Revenue (Billion US$), 2018 – 2023
Figure-66: Eli Lilly – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-67: GlaxoSmithKline – Global Revenue (Billion US$), 2018 – 2023
Figure-68: GlaxoSmithKline – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-69: Johnson & Johnson – Global Revenue (Billion US$), 2018 – 2023
Figure-70: Johnson & Johnson – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-71: Novartis AG – Global Revenue (Billion US$), 2018 – 2023
Figure-72: Novartis AG – Forecast for Global Revenue (Billion US$), 2024 – 2030
Figure-73: Takeda Pharmaceuticals – Global Revenue (Billion US$), 2018 – 2023
Figure-74: Takeda Pharmaceuticals – Forecast for Global Revenue (Billion US$), 2024 – 2030

List of Tables

Table-01: Global – Schizophrenia Drug Market Share by Treatment (Percent), 2018 – 2023
Table-02: Global – Forecast for Schizophrenia Drug Market Share by Treatment (Percent), 2024 – 2030
Table-03: Global – Schizophrenia Drug Market Share by Therapeutic Class (Percent), 2018 – 2023
Table-04: Global – Forecast for Schizophrenia Drug Market Share by Therapeutic Class (Percent), 2024 – 2030
Table-05: Global – Schizophrenia Drug Market Share by Distribution Channel (Percent), 2018 – 2023
Table-06: Global – Forecast for Schizophrenia Drug Market Share by Distribution Channel (Percent), 2024 – 2030
Table-07: Global – Schizophrenia Drug Market Share by Countries (Percent), 2018 – 2023
Table-08: Global – Forecast for Schizophrenia Drug Market Share by Countries (Percent), 2024 – 2030